Clinical Trial Update: A Study To Assess The Ability Of A Crossover Study Design To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients [Phase 1]

View source ↗

Summary

Phase 1 crossover study evaluating pregabalin for efficacy in post-traumatic neuropathic pain; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Neuropathic Pain

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Nerve Pain | Phase 1 | Status: COMPLETED | Results posted: 2010-02-24